Beam Therapeutics Inc. (BMV:BEAM)

Beam Therapeutics Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	53,765	41,131	36,504	52,503	109,210	91,742
Market Cap Growth	32.57%	12.67%	-30.47%	-51.92%	19.04%	-
Enterprise Value	37,517	25,217	22,278	34,634	93,056	88,401
Last Close Price	604.00	531.00	750.00	-	-	-
PS Ratio	52.62	31.08	5.72	44.18	102.75	192105.00
PB Ratio	3.03	2.69	2.20	3.67	6.44	18.77
P/TBV Ratio	3.03	2.69	2.20	3.67	6.44	18.77
P/OCF Ratio	-	-	-	119.48	-	-
EV/Sales Ratio	38.28	19.05	3.49	29.15	87.56	185109.63
Debt / Equity Ratio	0.16	0.22	0.18	0.25	0.18	0.44
Asset Turnover	0.05	0.05	0.27	0.04	0.05	0
Quick Ratio	5.89	4.67	5.79	4.82	5.93	2.93
Current Ratio	6.02	4.82	5.89	4.89	5.96	3.01
Return on Equity (ROE)	-47.19%	-43.94%	-15.46%	-37.06%	-69.13%	-112.32%
Return on Assets (ROA)	-23.48%	-20.26%	-7.88%	-15.02%	-15.41%	-27.30%
Return on Invested Capital (ROIC)	-28.15%	-25.35%	-10.67%	-22.40%	-22.36%	-34.19%
Return on Capital Employed (ROCE)	-41.30%	-45.10%	-14.10%	-30.30%	-18.80%	-38.00%
Earnings Yield	-14.15%	-19.09%	-6.14%	-10.74%	-6.96%	-4.22%
FCF Yield	-12.02%	-18.05%	-8.47%	-0.98%	-2.12%	-2.43%
Buyback Yield / Dilution	-14.73%	-6.69%	-10.19%	-9.01%	-37.44%	-621.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.